Riverwater Partners LLC Abbott Laboratories Transaction History

Riverwater Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$100.78 - $112.29 $28,722 - $32,002	-285 Reduced 9.93%	2,584 $281,000
Q1 2023 Apr 12, 2023	SELL	$96.86 - $114.01 $7,555 - $8,892	-78 Reduced 2.65%	2,869 $290,000
Q4 2022 Jan 12, 2023	SELL	$95.06 - $111.52 $2,756 - $3,234	-29 Reduced 0.97%	2,947 $0
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $54,379 - $62,960	562 Added 23.28%	2,976 $288,000
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $246,396 - $297,815	2,414 New	2,414 $262,000
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $245,713 - $299,631	-2,155 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $248,967 - $304,846	2,155 New	2,155 $303,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Riverwater Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Riverwater Partners LLC with notifications on news.